EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two Novel 1,4‐Naphthoquinone Derivatives as Potent Agents Against Multidrug‐Resistant Staphylococcus aureus and Pathogenic Gram‐Positive Bacteria

HyunChan Song iD, Haena Lee, Ji-Hyun Yoon iD, Hyunkyung Choi iD, Hakwon Kim iD, Ki-Young Kim iD

Drug Development Research · 2026

DOI: 10.1002/ddr.70353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von HyunChan Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biotechnology, Kyung Hee University, Yongin, Republic of Korea. Hauptthemen laut MEDLINE: Naphthoquinones, Anti-Bacterial Agents, Gram-Positive Bacteria, Methicillin-Resistant Staphylococcus aureus. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gyeonggi province, Korea University Guro Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐resistant bacteria such as Methicillin‐resistant Staphylococcus aureus (MRSA) and Quinolone‐resistant S. aureus (QRSA), are a growing problem, creating a need for the development of novel antimicrobial agents. In this study, we designed and synthesized two novel 1,4‐naphthoquinone derivatives, LHN‐1034 and LHN‐1035, and evaluated their antibacterial efficacy. Both compounds exhibited great antimicrobial activity against a group of Gram‐positive bacteria, including MRSA and QRSA, with Minimum Inhibitory Concentrations (MICs) ranging from 50 to 100 µM. Mechanism studies revealed that the antibacterial effect is oxygen‐dependent. The compounds act as redox‐cycling agents that induce intracellular reactive oxygen species (ROS), which disrupts cell membrane integrity and leads to cell lysis. In silico assessments predict low intestinal absorption and skin permeability, suggesting these compounds are suited for topical application. In conclusion, LHN‐1034 and LHN‐1035 are candidates for developing topical agents against resistant Gram‐positive infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesAnti-Bacterial AgentsGram-Positive BacteriaMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialReactive Oxygen Species

Stichwörter der Autor:innen

antimicrobial resistancenaphthoquinonetopical agents

Substanzen

NaphthoquinonesAnti-Bacterial Agents1,4-naphthoquinoneReactive Oxygen Species

Autor:innen und Institutionen

  • Graduate School of Biotechnology, Kyung Hee University, Yongin, Republic of Korea.
  • Department of Applied Chemistry, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, Republic of Korea.

ORCID-Profile: HyunChan Song, Ji-Hyun Yoon, Hyunkyung Choi, Hakwon Kim, Ki-Young Kim

Förderung

  • Gyeonggi province
  • Korea University Guro Hospital

Zitieren

APA

Song, H., Lee, H., Yoon, J. H., Choi, H., Kim, H., & Kim, K. Y. (2026). Two Novel 1,4‐Naphthoquinone Derivatives as Potent Agents Against Multidrug‐Resistant Staphylococcus aureus and Pathogenic Gram‐Positive Bacteria. Drug Development Research. https://doi.org/10.1002/ddr.70353

Vancouver

Song H, Lee H, Yoon JH, Choi H, Kim H, Kim KY. Two Novel 1,4‐Naphthoquinone Derivatives as Potent Agents Against Multidrug‐Resistant Staphylococcus aureus and Pathogenic Gram‐Positive Bacteria. Drug Development Research. 2026. doi:10.1002/ddr.70353

BibTeX
@article{Song2026,
  author = {Song, HyunChan and Lee, Haena and Yoon, Ji-Hyun and Choi, Hyunkyung and Kim, Hakwon and Kim, Ki-Young},
  title = {Two Novel 1,4‐Naphthoquinone Derivatives as Potent Agents Against Multidrug‐Resistant Staphylococcus aureus and Pathogenic Gram‐Positive Bacteria},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70353}
}
Kostenlos starten →